1. Acute pharmacological degradation of ERK5 does not inhibit cellular immune response or proliferation. Issue 11 (17th November 2022) Authors: You, Inchul; Donovan, Katherine A.; Krupnick, Noah M.; Boghossian, Andrew S.; Rees, Matthew G.; Ronan, Melissa M.; Roth, Jennifer A.; Fischer, Eric S.; Wang, Eric S.; Gray, Nathanael S. Journal: Cell chemical biology Issue: Volume 29:Issue 11(2022) Page Start: 1630 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Discovery of an AKT Degrader with Prolonged Inhibition of Downstream Signaling. Issue 1 (16th January 2020) Authors: You, Inchul; Erickson, Emily C.; Donovan, Katherine A.; Eleuteri, Nicholas A.; Fischer, Eric S.; Gray, Nathanael S.; Toker, Alex Journal: Cell chemical biology Issue: Volume 27:Issue 1(2020) Page Start: 66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Exploring the target scope of KEAP1 E3 ligase-based PROTACs. Issue 10 (20th October 2022) Authors: Du, Guangyan; Jiang, Jie; Henning, Nathaniel J.; Safaee, Nozhat; Koide, Eriko; Nowak, Radosław P.; Donovan, Katherine A.; Yoon, Hojong; You, Inchul; Yue, Hong; Eleuteri, Nicholas A.; He, Zhixiang; Li, Zhengnian; Huang, Hubert T.; Che, Jianwei; Nabet, Behnam; Zhang, Tinghu; Fischer, Eric S.; Gray,... Journal: Cell chemical biology Issue: Volume 29:Issue 10(2022) Page Start: 1470 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗